Trump Administration Punts on Medicare Policy Changes

The Trump administration is punting on premium spikes for Medicare, seeking to delay policy changes until after his 2020 reelection bid, The Washington Post reports. An up to 19 percent increase is expected with the president’s plans to do away with Medicare rebates paid to firms that manage pharmacy insurance by drug makers. Proponents of health care reform have long derided these rebates as a kickbacks and an incentive to drive up the cost of medications. Pharmacy benefit managers, which will be directly affected by the plans to halt rebates, maintain that they stabilize premiums and argue that nixing them will drive up premiums, which the administration's actuaries confirmed. Long lead times to put the plan into place was cited as the reason for the delay.

          | TBA Law Blog